Clinical trial NCT05455437: Monitoring and Evaluation Study of Project ECHO for ILD
Official title: Monitoring and Evaluation Study of Project ECHO for ILD
Study type: OBSERVATIONAL
Overall status: UNKNOWN
Conditions: Interstitial Lung Diseases
Keywords: Progressive Fibrosing Interstitial Lung Disease
Idiopathic Pulmonary Fibrosis
Interstitial Lung Disease Associated With Systemic Sclerosis
Myositis-Associated Interstitial Lung Disease
Sarcoidosis
Hypersensitivity Pneumonitis
Pulmonary Fibrosis
Lead sponsor: Pulmonary Care and Research Collaborative Limited
Sponsor class: OTHER
Collaborators: name: Genentech, Inc.
First posted: 2022-07-13
Enrollment: 200
Sex: ALL
Standard ages: CHILD
ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: OTHER
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Pulmonologists and primary care physicians who participate in Project ECHO for ILD.

Brief summary: The study will utilize pre-post survey measures to evaluate Project ECHO for ILD with respect to an initial set of practice and clinical outcomes and relies on questionnaire data obtained from providers participating in Project ECHO for ILD at baseline, at 6 months, and at study end.

Detailed description: Project ECHO (Extension for Community Healthcare Outcomes) is a knowledge-sharing model to expand the capacity of the health care workforce so that more people can get high quality care for their health conditions in or near the communities where they live. The model brings specialty disease expertise to community providers through its hub-and-spoke networks. The model relies on videoconferencing to connect local providers in non-urban or underserved communities (spoke sites) with an interdisciplinary team of specialist providers at academic medical centers (hubs) during virtual "teleECHO" clinic sessions, which include brief educational lectures and case-based, experiential learning. It is a guided, technology-enabled collaborative practice model in which community providers become experts in an area of community need within the scope of their practice, operating with increasing independence as their skills and self-efficacy grow. The model establishes meaningful, ongoing relationships with hub specialists who serve as telementors for spoke providers and relies on case-based learning from presentations of real-world de-identified patient cases.

The overarching goal of the project is to implement and evaluate an adaptation of the ECHO model to interstitial lung disease (ILD) diagnosis and care among primary care physicians (PCPs) and community pulmonologists in non-urban or underserved communities.

Eligibility criteria: Inclusion Criteria:

* Pulmonologists and primary care physicians who participate in Project ECHO for ILD.

Exclusion Criteria:

-

Primary outcomes:
measure: Impact on procedural knowledge
timeFrame: Up to 18 months
measure: Impact on local care utilization
timeFrame: Up to 18 months
Secondary outcomes:
measure: Time to ILD diagnosis
timeFrame: Up to 18 months
measure: Content expert facilitation
timeFrame: Up to 18 months
Other outcomes:
Locations:
city: Boston
country: United States
facility: Pulmonary Care and Research Collaborative, Ltd.
state: Massachusetts
Study officials:
affiliation: Pulmonary Care and Research Collaborative, Ltd.
name: Aliaa Barakat, PhD
role: PRINCIPAL_INVESTIGATOR
References: